Pronota NV - Product Pipeline Analysis, 2013 Update - New Market Report
Pronota NV (PNV) is a diagnostic service provider company. The company research and develops solutions for early life-threatening conditions. It provides products such as pre-eclampsia, cardio-renel syndrome, ovarian cancer and sepsis. PNV provide services such as non-invasive, validated and diagnostics, patent protected protein chemistry techniques, advanced separation sciences, high-end mass spectrometry and in house developed proprietary bioinformatics tools. Its technologies include MASStermind, a protein biomarker discovery platform that enables identification and relative quantitation of proteins; and MASSterclass, a mass spectrometry...
View full press release